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Abstract
The growth factor interleukin-3 (IL-3) promotes the survival and growth of multipotent hematopoietic progenitors and
stimulates myelopoiesis. It has also been reported to oppose terminal granulopoiesis and to support leukemic cell growth
through autocrine or paracrine mechanisms. The degree to which IL-3 acts at the posttranscriptional level is largely
unknown. We have conducted global mRNA decay profiling and bioinformatic analyses in 32Dcl3 myeloblasts indicating
that IL-3 caused immediate early stabilization of hundreds of transcripts in pathways relevant to myeloblast function.
Stabilized transcripts were enriched for AU-Response elements (AREs), and an ARE-containing domain from the interleukin-6
(IL-6) 39-UTR rendered a heterologous gene responsive to IL-3-mediated transcript stabilization. Many IL-3-stabilized
transcripts had been associated with leukemic transformation. Deregulated Abl kinase shared with IL-3 the ability to delay
turnover of transcripts involved in proliferation or differentiation blockade, relying, in part, on signaling through the Mek/
Erk pathway. These findings support a model of IL-3 action through mRNA stability control and suggest that aberrant
stabilization of an mRNA network linked to IL-3 contributes to leukemic cell growth.
Citation: Ernst J, Ghanem L, Bar-Joseph Z, McNamara M, Brown J, et al. (2009) IL-3 and Oncogenic Abl Regulate the Myeloblast Transcriptome by Altering mRNA
Stability. PLoS ONE 4(10): e7469. doi:10.1371/journal.pone.0007469
Editor: Mikhail V. Blagosklonny, Roswell Park Cancer Institute, United States of America
Received March 14, 2009; Accepted May 7, 2009; Published October 15, 2009
Copyright:  2009 Ernst et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the Hillman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: steinman@pitt.edu
Introduction
The growth factor Interleukin-3 (IL-3) is a pleiotropic cytokine
protein that promotes the survival and proliferation of multipotent
hematopoietic progenitors, and stimulates the development of
multiple hematopoietic lineages. While IL-3 supports early
myelopoiesis, it opposes terminal granulocytic differentiation. We
and others have shown that IL-3 prevents execution of the G-CSF
differentiation program in the murine 32Dcl3 model of granulo-
poiesis [1–3]; IL-3 also opposes terminal granulocytic differenti-
ation of normal human myeloid precursor cells [4,5].
Heightened expression of hematopoietic growth factors such as
IL-3 could support leukemia progression through an autocrine
mechanism. High expression of the IL-3 receptor has been noted in
leukemic blasts [6] and correlates with enhanced cycling of blasts
and poor patient oucomes [7]. IL-3 is frequently expressed by
leukemic myeloblasts [8] and can promote clonogenicity of primary
blasts [9]. IL-3 production by imatinib resistant CML blasts can
render other leukemic blast cells resistant through paracrine
stimulation [10]. In one experimental leukemic model, downreg-
ulation of an IL-3 autocrine loop decreased leukemogenicity [11].
While most investigations of the action of hematopoietic
cytokines such as IL-3 have focused on cytokine signal transduc-
tion leading to transcriptional activation (reviewed in [12]), limited
evidence suggests that the cellular response to IL-3 cytokine
stimulation also involves posttranscriptional mechanisms. Matsui
et. al. [13] have reported that Bim-mediated apoptosis is prevented
in an IL-3- dependent B-cell line by IL-3-mediated decay of Bim
transcript. In addition, IL-3 was shown to increase mRNA stability
of its own receptor subunit in mature eosinophils [14]. We sought
to determine whether proliferating myeloblasts expressed a distinct
profile of mRNA half-lives that was controlled by hematopoietic
cytokines such as IL-3.
The regulation of mRNA turnover often occurs via the
39-untranslated region (39-UTR) at AU-rich elements (ARE’s)
that are recognized and competitively bound by RNA-binding
proteins that stabilize or destabilize the transcripts. Roughly 4000
genes are known to contain these elements and consist primarily of
short-lived transcripts. Three classes of AU-rich sequences have
been described including those with single or noncontinuous
canonical UUAUUUAWW motifs (Class I), those containing
overlapping or continuous copies of the motif (Class II), and a
3rd class of U-rich sequences lacking that the AU-motif (Class III)
[15–17].
Coordinate stabilization of multiple mRNAs allows coherent
cellular responses to external stimuli. Several studies indicate that
mRNAs in the same pathways share similar decay kinetics and
could share overlapping stability control pathways [18]. For
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instance, interferon gamma synchronously increases expression of
proinflammatory molecules via mRNA stabilization [19]. The
coordinate stabilization of multiple transcripts has also been
reported upon T-cell activation [20] and during muscle and
neuronal differentiation [21,22]. However, no systematic analysis
of mRNA turnover in myeloblasts exposed to proliferative
hematopoietic cytokines has been performed. Better understand-
ing of the control of mRNA metabolism in myeloblasts could
illuminate posttranscriptional defects that occur in myeloprolifer-
ative disorders or myeloid leukemias.
As a model for studying hematopoietic cytokine regulation of
mRNA turnover, we have used the murine myeloblast cell line
32Dcl3. These nonleukemic, diploid cells are IL-3-dependent for
proliferation and survival and differentiate into functional
neutrophils when IL-3 is replaced by G-CSF in culture [23].
32Dcl3 cells have frequently been used to analyze molecular
components of cytokine signaling pathways [24–26].
We have previously reported that 32Dcl3 myeloblasts growing
in IL-3 express high basal levels of p21WAF1 mRNA and protein,
and that p21 inhibits the neutrophilic differentiation of these cells
[27]. Because reports in nonhematopoietic cells have demonstrat-
ed that p21 transcript turnover changed in response to cellular
stress, growth factors and differentiation stimuli, we posited that
IL-3 induction of p21 could reflect mRNA stabilization. In this
report, we demonstrate that p21 is just one of many transcripts
that are stabilized by IL-3. Of note, IL-3 stabilized these mRNAs
without the need for IL-3- mediated transcription because IL-3
was added after transcriptional blockade. These posttranscription-
ally regulated mRNAs are functionally coordinated, mapping to
several key pathways characteristic of the myeloblast phenotype.
In particular, IL-3 opposed the decay of transcripts related to cell
cycling. Bioinformatic analysis indicated enrichment of AU-rich
sequences in the 39 UTR of transcripts stabilized by IL-3. These
findings support a model in which IL-3 supports myeloblast
growth through signals that encroach on shared 39-UTR motifs in
a substantial portion of the transcriptome.
Oncoproteins such as v-Abl can render 32D myeloblasts IL-3-
independent for growth. Activated Abl kinase has been shown to
overlap with IL-3 in its activation of downstream signals [28]. We
sought to determine whether v-Abl kinase activity could mimick
IL-3 in controlling the rate of decay of transcripts linked to
myeloblast growth and survival. Results indicated that Abl kinase
slowed the decay of select transcripts, similar to IL-3.
Results
p21 as a model for posttranscriptional control by IL-3
In the 32Dcl3 myeloblast model, IL-3 supports proliferation and
survival and inhibits cellular differentiation. If IL-3 coordinates
this phenotype in part through stabilizing mRNAs, then a subset of
transcripts linked to these functions will decay slower in IL-3 than
when IL-3 is withdrawn or replaced with the differentiating
cytokine G-CSF. Figure 1 demonstrates that p21 mRNA levels
decrease when cells are switched from IL-3 to G-CSF (Figure 1A).
In order to determine whether cytokine exposure directly affected
transcription of p21, 32Dcl3 cells were stably transfected with an
EGFP reporter driven by the p21 promoter. Cell were washed,
resuspended in IL-3 or G-CSF, and EGFP fluorescence was
measured two days later using flow cytometry. EGFP expression
varied by less than 10% between culture conditions, indicating a
minimal effect of IL-3 on p21 transcription and bolstering a
posttranscriptional basis for differences in p21 mRNA levels
(Figure 1B). Actinomycin D chase experiments confirmed that the
half-life of p21 in physiologic [29] (1 ng/ml) IL-3 was roughly 3.5
times longer than when cells were maintained in IL-3 –deficient
(0.01 ng/ml) medium or in G-CSF (Figure 1C). Furthermore, the
addition of IL-3 to cells cultured overnight in G-CSF restored p21
stability. Stably transfected 32Dcl3 cells harboring exogenous
human p21 cDNA lacking the 39-UTR (untranslated region)
exhibited increased stability that did not change significantly in
IL-3-deficient medium. In contrast, the mRNA signal correspond-
ing to endogenous p21 bearing the full-length 39-UTR was
markedly less stable in IL-3-deficient medium than with
physiologic IL-3 (Figure 1D). Having shown that IL-3 upregulated
p21 mRNA by increasing it’s stability in 32Dcl3 mouse
myeloblasts, we determined whether human p21 was also subject
to similar regulation. Full-length human p21 (including untrans-
lated regions) cDNA was stably transfected into 32Dcl3 cells. The
decay of exogenous human p21 and endogenous mouse p21
transcripts were detected using species-specific probes on Northern
blots of Actinomycin D chase experiments (1E). IL-3 stabilized
transcripts of either species similarly. This indicated that enhanced
expression of p21 in 32Dcl3 myeloblasts reflected a longer p21
mRNA half-life due to IL-3 that was dependent on the 39-UTR of
the p21 transcript.
IL-3 stabilizes a network of transcripts involved in cell
cycling
We have previously demonstrated that specific RNAi-mediated
downmodulation of p21 accelerated granulocytic differentiation in
the 32Dcl3 cell line [27], indicating a differentiation-suppressive
role for p21 in these myeloblasts. The posttranscriptional
stabilization of p21 by IL-3 (noted above) could contribute to
IL-3 blockade of 32Dcl3 cell differentiation. We therefore
determined whether IL-3 altered the turnover of a number of
transcripts linked to myeloblast growth or function, in addition to
p21. In order to derive a global list of candidate IL-3 targets, we
conducted kinetic microarrays [30] in which 32Dcl3 cells were
washed free of IL-3, exposed to actinomycin D to stop
transcription and then treated with either IL-3-replete or IL-3-
deficient medium (Supplemental Figure S1). Cells were harvested
2 and 4 hours after cytokine re-addition and Affymetrix 430A-2.0
microarrays were run on samples harvested from each condition at
0, 2 and 4 hours. These time points were chosen to capture labile,
cytokine-responsive transcripts within a temporal window in which
cells were fully viable. Two independent experiments were run. A
series of analyses were conducted in order to rank-order probe sets
by the degree to which IL-3 stabilized the corresponding
transcripts (see Supplemental Methods S1).
To perform these analyses, a novel algorithm was developed.
The degree to which IL-3 stabilized a transcript was denoted by
the difference between the transcript’s decay rate in cells exposed
to IL-3 replete- versus IL-3-deficient medium. The algorithm
begins by calculating the average area between the mRNA decay
curve of each gene probe set in the presence of IL-3 and the decay
curve of that probe set in IL-3-deficient medium (garea). The greater
the value of garea, the larger the difference in transcript decay with
and without IL-3 depletion. We then adjusted garea based on the
time point 0 signal intensity to correct for the greater effect that
noise would have on garea for probes with the lowest signal intensity
(see Supplemental Methods S1). This adjustment led to a score for
each probe set termed gscore. Higher gscore values were expected to
correspond to increased transcript stabilization by IL-3 as
manifested by a greater difference in the adjusted area between
the decay curve in IL-3-replete and -deficient medium. We used
our algorithm to rank order the 22,690 probe sets from those
corresponding to transcripts that were the most-stabilized by IL-3
RNA Stabilization by IL-3
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to those least-stabilized by IL-3 (See Supplemental Methods S1), as
shown on scatter plots (Supplemental Figure S2).
Confidence in the rank-ordered list was bolstered by the
identification of p21 as a strongly stabilized transcript. Out of the
22,690 probe sets on the microarray, the two probes corresponding
to p21 occupied the 14th-most and 17th-most stabilized positions.
The probesets included on microarrays used for these studies
represent 13,486 unique transcripts based on Entrez gene ID’s.
When ordered by unique transcript (i.e. averaging out probesets that
recognize distinct portions of the transcript), p21 was the 10th-most
stabilized transcript out of 13,486. The list of probesets arranged by
IL-3-mediated stability is shown in Supplemental Table S1. A table
of genes ranked from most- to least-stablized derived from taking the
mean value for probesets annotated to the same gene is shown in
Supplemental Table S2. The listings in both supplemental tables
were in close agreement in the sense that we found either list would
produce similar results in our downstream analysis.
The primary conclusion from this microarray analysis was that
transcripts represented by 5290 probe sets were measured to decay
slower in 1 ng/ml IL-3 than without it, with most of the total
measured magnitude of stabilization occuring in the top 1000
probe sets (Table S1, Figure S2). IL-3 was therefore concluded to
stabilize hundreds of gene transcripts in 32Dcl3 myeloblasts.
In order to validate microarray-based rankings, Northern
blotting for p21 and several other transcripts was conducted on
extracts of cells from Actinomycin D chase experiments conducted
in the presence or absence of IL-3 (Figure 2A). For each of seven
independent experiments shown on Northern Blots, p21 was
probed as a positive control and manifested a decay half-life of
3.6 hours in IL-3 and 1.5 hours without IL-3 on average (Figure 2B).
The probe sets for the loading control utilized, GAPDH, were at
positions 10,018, 10,420, and 14,173 out of all queried probe sets
and manifested minimal cytokine-dependent variation. It was
evident in each case that IL-3 dramatically retarded the degradation
of transcripts that otherwise occurs in the absence of this cytokine.
In several cases transcripts were undetectable within 2 hours unless
IL-3 was present. Results are plotted in Figure 2B. It is notable that
the IL-3 stabilized transcripts shown on duplicate Northern Blots in
Figure 2 have been associated with regulatory roles in normal or
malignant hematopoiesis (Table 1).
Figure 1. Posttranscriptional p21 mRNA regulation by IL-3. A) Downregulation of p21 mRNA in differentiating myeloblasts. Northern blot
analysis of total RNA from 32Dcl3 cells propagating in IL-3 (1 ng/mL) or following treatment with G-CSF (100 ng/mL) for indicated times. Cells
remained viable over this time course. RNA harvested daily was probed with 32P-labeled murine p21 cDNA. Ethidium bromide stained 18S RNA is
provided as a loading control. B) Comparable p21 promoter activity in proliferating and differentiating myeloblasts. 32Dcl3 cells stably transfected with
EGFP driven by the murine p21 promoter were washed and either resuspended in IL-3 containing medium (1 ng/ml) or in G-CSF-containing medium
(30 ng/ml) and EGFP expression measured 48 hours later by flow cytometry. Experiment was done twice with triplicate determinations. C) IL-3
stabilizes p21 mRNA. The half-life of p21 under indicated conditions was determined as described in Materials and Methods. p21 signals normalized
against GAPDH on autoradiograms were plotted and mean decay rate of 3 independent experiments were determined. GAPDH remains stable under
these conditions (Supplemental Table S1). D) IL-3-regulated turnover requires 3-UTR. Cells were stably transfected with p21 lacking UTR sequences, and
decay of endogenous p21 (endo) compared to exogenous p21 (exo) cDNA was measured in chase experiments as above. E) Comparable decay of
human and murine p21. Stable transfectants containing human p21 mRNA including the full-length 39-UTR were exposed to medium with (+) or
without (2) IL-3 for 2 or 4 hours after Actinomycin D as indicated, and mRNA blotted.
doi:10.1371/journal.pone.0007469.g001
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Functional grouping of transcripts stabilized by IL-3
In order to uncover shared biological functions between the
transcripts that were stabilized by IL-3, gene ontology (GO)
analysis was conducted for different subsets of the stability-ranked
list, using STEM software [31]. The functional categories that
were significantly enriched among the top 1000 IL-3 responsive
transcripts are listed in Supplemental Table S3. IL-3 dispropor-
tionately decreased the turnover of transcripts annotated to the
GO categories cell cycle (p,2610210), RNA processing (1026),
and other related categories. As further support for coordinated
Figure 2. IL-3 regulated turnover of transcripts. A–D. Northern Blots of IL-3 stabilized transcripts. Northern blots of samples from one (D) or two
independent experiments each (A, B, C). RNAs were prepared from 32Dcl3 cells washed free of IL-3, transcriptionally arrested and then exposed to
medium alone (2) or reexposed to 1 ng/ml IL-3 (+) for indicated times. Blots were probed with riboprobes prepared for transcripts selected from
microarray-based rank listings. GAPDH expression is shown as a loading control. p21 is probed as a positive control in each of the 7 experiments. For
each time point, lower expression of the sample lacking IL-3 (2) is evident. E. left: Graphic representation of Northern blot results. Decay curves are
plotted from the data in A–D quantitated with Image J software. *p,= 0.05, **p,0.002 comparison of value with and without IL3. right: Transcript
half-lives calculated as described in Methods for IL-3 positive and -negative conditions.
doi:10.1371/journal.pone.0007469.g002
RNA Stabilization by IL-3
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function of the IL-3-stabilized genes, Ingenuity pathway analyses
linked five out of the top fifteen stabilized transcripts (and 25 out of
the top 250 stabilized transcripts) into a proliferation-related
interaction network (data not shown). This network was scored at
a highly significant level of 47, using algorithms that assign a score
of 2 to a 1% likelihood of random association [32].
Candidate motifs involved in IL-3-mediated stabilization
A bioinformatics approach was used to uncover common motifs
among the transcripts ranked by differences in their turnover rate
with and without physiologic IL-3. As a first indication of whether
IL-3 was acting through discrete motifs, we determined whether
AU-Rich Element (ARE)-containing transcripts were overrepre-
sented among those stabilized by IL-3. The ranked transcript
dataset derived from our kinetic microarrays was plotted against
the ARED database version 3.0 [33] that is comprised of genes
reported to have functional AU-rich sequence elements in their
39-UTR. The set of AU-rich genes was defined based on the
presence in ARED database 3.0 [33]. As the ARED database
contains human genes, mouse genes were mapped to a human
gene if a homolog relationship was present in the homologene.data
file provided by the National Center for Biotechnology Informa-
tion (NCBI). The presence or absence of ARE’s logged into
ARED is noted individually for each probe set in our database
(Supplemental Table S4). The difference in the cumulative
number of observed matches with the ARED database based on
ranking in our list and the expected number if we had randomly
ordered our list was calculated. The lower curve in Figure 3A
shows calculated AU-rich accumulation rates if the AU-sequences
had been randomly distributed. The 95th percentile curve for AU-
accumulation for randomly-ordered probesets is shown. We
observed increasing concentration of AU-sequences in probe sets
corresponding to the first 4000 transcripts, with the steepest
increase among the transcripts that were most stabilized by IL-3,
particularly in the first 780 transcripts. This is evident by the slope
of cumulative observed-minus-expected ARED transcripts as shown
in Figure 3A. The steeper the positive slope, the higher the
concentration of AU-containing transcripts among the corre-
sponding probe sets. Based on the hypergeometric distribution the
p-value enrichment for ARED transcripts among the first 250
transcripts is ,1029 and among the first 4000 transcripts it is
,10222. Similar results were obtained when unique transcripts
were ranked (averaging values of corresponding probe sets) and
used as when the analysis included all probe sets (data not shown).
It should be noted that while AU-rich transcripts tend to be short-
lived, there was no a priori reason why the rapid decay of these
mRNAs would be inhibited by IL-3. The observation of ARED
clustering among IL-3-stabilized transcripts suggested that IL-3
signaled through pathway(s) that altered mRNA regulation at
specific sequences associated with AU-binding proteins.
In order to validate the importance of ARE-containing
sequences in transcripts stabilized by IL-3, we investigated whether
IL-3 responsiveness mapped to a domain containing AU-
sequences within the 39-UTR of interleukin-6. The IL-6 gene
contains the shortest 39-UTR (420 bp) of those murine transcripts
whose stabiliization by IL-3 was validated in Figure 2. We
therefore constructed a fusion construct that linked EGFP cDNA
to an ARE-containing 158-bp murine IL-6 39-UTR domain that
contains 4 AU-rich elements. This construct or an EGFP control
plasmid were stably transfected into 32Dcl3 cells. EGFP turnover
was subsequently monitored using Actinomycin D chase assays.
The IL6-UTR domain conveyed IL-3-dependent turnover to the
EGFP transcript as shown in Figure 3B.
IL-3 signaling pathways involved in transcript
stabilization
IL-3 signals through multiple pathways to support hematopoi-
etic cell growth and survival. Among the pathways and kinases
activated by IL-3 in cytokine-dependent cell lines such as 32Dcl3
are PI3K, Jak2/Stat5, PKC, src, ras/raf/mek/erk,MAPK/p38 or
Jnk pathways (for review [34]). Activation of each of these
pathways has been associated with mRNA turnover control
(reviewed in [35]). In order to garner insight into pathways
through which IL-3 could coordinately stabilize myeloblast
transcripts, we separately inhibited PI3K, JAK/Stat, PKC,
Mek/Erk, Jnk, Src, Syk and AMPK signaling pathways using
optimized inhibitor concentrations and determined whether any of
these pathways modulated IL-3-induced transcript stabilization.
Table 1. Hematopoietic roles of validated IL-3 posttranscriptional targets.
Gene name position in rank list Notes reference
Pik3cd (PI3-kinase delta) 3 Nassociated with myeloid leukemia [52,53].
Nsupports leukemic cell growth and survival
IL-6 5 N affects differentiation or proliferation [54]
Nproduced by AML blasts
zfp36l1 (Brf1, tis11b) 13 Nassociated with t(8:11) myeloid leukemia proliferation [55]
cdkn1a (p21) 14 Ninhibits 32D differentiation [27,56]
Nassociated with resistant AML
zfp36l2 (Brf2, tis11d) 39 Nupregulated in resistant myeloid leukemia [57,58]
Ninvolvement at a leukemic breakpoint
myb 58 Nrole in hematopoiesis and promotion of leukemia [59–61]
Ninhibits 32Dcl3 differentiation and apoptosis
pim-1 103 Nrole in Flt3-mediated survival in myeloid leukemia [62]
cited-2 273 Nessential for hematopoiesis [63]
The ranked position (out of 22,690 probe sets assayed) of Northern-blot-validated transcript probe sets and references highlighting their role in normal or malignant
hematopoiesis are shown. For transcripts linked to multiple probe sets, the first occurrence of transcript in the ranked probe set list is shown.
doi:10.1371/journal.pone.0007469.t001
RNA Stabilization by IL-3
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7469
Inhibitors were added 15–20 minutes before IL-3 addition in
Actinomycin D chase assays. Of these inhibitors, only the Mek1
inhibitor U0126 decreased the ability of IL-3 to stabilize
transcripts. This inhibitor was used at a concentration of 10 uM
that sufficed to block Erk phosphorylation in these cells (Figure 4A).
Because U0126 and subsequently IL-3 were added after
transcriptional blockade, these results indicated a role for Erk
signaling in the posttranscriptional stabilization of transcripts by
IL-3 (rather than an effect on transcription). The Erk pathway
was of particular interest because it has previously been linked
to posttranscriptional stabilization of p21, IL-8 , MIP 1alpha,
IL-1beta, TNFalpha, cox-2 and GM-CSF mRNAs [36–42] (see
Figure 3. Contribution of AU-rich elements to IL-3 control of transcript stability. A. Enrichment for ARED sequences in IL-3-stabilized
transcripts. The excess accumulation of AU-rich transcripts as a function of position in the ranked list is shown (blue). An upward slope indicates that
AU-rich sequences are accumulating at a faster rate than predicted by random ranking; a downward slope indicates that ARE’s are accumulating at a
slower rate than random transcript ranking would predict. The 95th percentile confidence interval curve for random rankings is also plotted for
comparison (red). B. IL-3 response element mapping in the IL6 promoter. A 158-bp IL6-39-UTR fragment destabilizes a heterologous transcript in the
absence, but not in the presence, of IL-3. Northern blotting of RNA from 32Dcl3 cells stably transfected with EGFP or an EGFP-IL6UTR transgene.
GAPDH indicates loading and pik3cd demonstrates endogenous transcript regulation in the presence and absence of IL-3. Representative blots of
two independent experiments are shown.
doi:10.1371/journal.pone.0007469.g003
RNA Stabilization by IL-3
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Figure 4. IL-3-mediated RNA stabilization involves MEK/ERK signaling. A. IL-3 activates pErk in 32Dcl3 myeloblasts. Upregulation of phospho-
Erk at 15 minutes after addition of IL-3 to 32Dcl3 myeloblasts washed free of IL-3 is evident (I). Pre-incubation for 20 minutes with the Mek1 inhibitor
U0126 (at 10 uM) blocks this effect (IU), as does washout of IL3 (2). B. Downregulation of IL-3 induced transcript stabilization by Mek/ERK blockade. Cells
were incubated with 10 uM of 10 uM of erk inhibitor U0126 concurrent with Actinomycin D. 1 ng/ml IL-3 (+) or vehicle was added 20 minutes later
(time 0) and RNA was harvested 2 or 4 hours after IL-3 addition. p21 and pik3cd expression on Northern blots normalized to GAPDH is shown, with
time 0 value set to 1.0 (n = 3). C. Imatinib inhibits mRNA stability in v-Abl 32Dcl3 cells. Imatinib (IMAT) or DMSO vehicle (2) were added following a 20
minute preincubation with actinomycin D, at time 0 as indicated. Cells were harvested for RNA at 0 and 4 hours and Northern Blots were probed with
pik3cd, p21, pim1 and GAPDH. D. Erk phosphorylation. Phosphorylation of Erk in v-Abl transformants of 32Dcl3 is prevented by 15 minute incubation
with imatinib (I, 5 uM) or with U0126 (U, 10 uM). E. Effects of imatinib and U0126 on transcript turnover. Data represents three separate experiments.
Quantitation of RNA expression on Northern blots normalized to GAPDH, with time 0 value set to 1.0 is shown. F. Model of posttranscriptional
pathway. Dashed line indicates possible involvement of additional signals.
doi:10.1371/journal.pone.0007469.g004
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also commentary by Sugiura [43]). However, inhibition of the
MEK/Erk pathway partially blocked but did not completely
abnegate transcript stabilization by IL-3 (Figure 4B).
Abl kinase recruitment of IL-3 posttranscriptional
stabilization pathway
Conceivably, oncoproteins could hijack posttranscriptional
pathways normally used by growth factors to sustain proliferation
and prevent differentiation of immature cells. 32Dcl3 myeloblasts
transduced with the v-Abl oncoprotein were used to test whether
this constitutively-active kinase affected mRNA turnover and
shared mRNA targets with IL-3. We have shown that v-Abl
renders 32Dcl3 cells IL-3 independent for growth and blocks
differentiation [2]. Figure 4C shows that active abl kinase
(compared with imatinib-inhibited v-Abl) increased the half-life
of transcripts included among IL-3-stabilized transcripts profiled
in Figure 2. As in the case of IL-3, active v-Abl promoted Erk
phosphorylation in 32Dcl3 myeloblasts (Figure 4D). Inhibition of
Erk phosphorylation by the Mek1 inhibitor U0126 partially
blocked v-Abl stabilization of transcripts in comparison with
imatinib (Figure 4E).
Discussion
Changes in the stability of messenger RNAs represent an
efficient way rapidly to alter gene expression and cellular
phenotypes, particularly if multiple mRNAs that share a functional
pathway are stabilized or destabilized in synchrony. Coincident
increases (or decreases) in mRNA transcription and in mRNA
stability can magnify signals, whereas discordant transcription and
mRNA stability enforces precise temporal or developmental
regulation of transcript levels. Extensive research has delineated
transcriptional control pathways during myelopoiesis that are
disrupted in leukemia and more recent investigations have
highlighted differentiation-specific or leukemia-related posttran-
scriptional modulation of translation by microRNAs. The impact
of mRNA stability control on normal and malignant myelopoiesis
has been less well characterized despite evidence that changes in
turnover rates of certain mRNAs can dramatically affect cellular
behavior (for review, [35]).
This paper delineates the range of posttranscriptional mRNA
regulation by IL-3 in murine myeloblasts as evidence that IL-3
controls myeloblast function through its effects on mRNA turnover
rather than solely through transcriptional activation. The popula-
tion of IL-3-stabilized transcripts was captured through analysis of
the decay rate of transcripts in IL-3 -replete or -deficient medium
after transcriptional blockade with Actinomycin D. While mRNA
half-life changes have previously been studied in LPS-exposed
monocytes, activated T cells, flavopiridol-exposed lymphocytes and
HepG2 cells [18,44–46], a systematic study of growth factor-
directed transcript turnover in myeloblasts has not hitherto been
conducted. We have previously reported a robust bioinformatics
approach to short kinetic gene expression data sets [47] and in this
study we have extended that work to optimize the comparison of
microarray sets charting transcript decay under two discrete
conditions. The algorithm that we used to compare global mRNA
decay rates under these conditions will be useful for other kinetic
microarray analysis of mRNA stability.
This analysis ranked transcripts from most- to least-stabilized by
IL-3. Northern blotting of cells incubated with or without IL-3
confirmed IL-3 mediated stabilization of select transcripts ranked
from position 3 to position 273 out of 22,690 probe sets on an
Affymetrix array (Table 1, Figure 2). The number of transcripts
whose decay rate is slowed by IL-3 is therefore substantial,
supporting the relevance of this posttranscriptional pathway to
IL-3-supported survival, growth and differentiation blockade of
32Dcl3 myeloblasts. Many of the proteins encoded by IL-3
stabilized transcripts have been shown to support leukemic cell
growth and survival and/or to inhibit differentiation in 32Dcl3
myeloblasts (for examples, Table 1). These results supported a
significant role for IL-3-mediated RNA stabilization in sustaining
myeloblast growth and suggested that elucidation of IL-3-
stabilized transcripts could reveal genes and pathways that support
blast cell proliferation in myeloid leukemias. In this context, it was
notable that two of the five most stabilized genes, pik3cd and IL6
are already directly targeted by therapeutics in clinical trials of
hematologic malignancies (NCT00710528, NCT00402181).
It is notable that transcripts involved in RNA processing were
significantly enriched as IL-3 stabilization targets upon gene
ontology analysis. Enhanced expression of this class of genes could
serve to bolster IL-3 effects on decay rates, or alternatively, to limit
IL-3 posttranscriptional effects. Two transcripts that were
markedly stabilized by IL-3, BRF1 (zfp36l1) and BRF2 (zfp36l2),
destabilize mRNA transcripts at AREs [48,49]. These gene
products have been linked to leukemia and may facilitate
degradation of apoptotic or antiproliferative transcripts in
myeloblasts. Alternatively, BRF1 and 2 transcript stabilization
could herald a negative feedback loop that limits the durability of
IL-3-sustained messages. This possibility is supported by a recent
global assessment of epidermal growth factor signaling that
identified early upregulation of BRF1 and 2 as part of a negative
feedback loop that was characterized by BRF destabilization of
mitotic transcripts [50].
Our data indicated that some of the same transcripts stabilized
by IL3 are stabilized by the v-abl oncoprotein in an imatinib-
dependent manner. This raises the prospect that many of the
growth-promoting mRNAs that are stabilized by IL3 are also
stabilized by v-Abl, potentially through the same terminal
mediator(s). Such a mechanism could contribute to the ability of
v-Abl to substitute for IL-3 in supporting the growth of this
myeloblast cell line. Because multiple oncogenes can render these
myeloblasts factor-independent, it is conceivable that the appro-
priation of growth factor pathways regulating RNA decay is a
general feature of leukemogenesis. IL-3 and v-Abl share
overlapping signaling pathways, including activation of the
Mek/Erk pathway. This pathway has been shown to stabilize
several transcripts (as discussed in Sugiura [43]). In our
experiments, the Mek inhibitor U0126 partially inhibited IL-3
and v-Abl-mediated transcript stabilization. This suggests that Erk
cooperates with other pathways downstream of IL-3 and v-Abl to
stabilize target mRNAs, as has been reported for Erk-mediated
TNF-alpha transcript stabilization [40].
Studies are planned to dissect in detail the downstream
mediators of IL-3 and v-Abl posttranscriptional control of mRNAs
in order to facilitate the development of ‘‘post-transcriptional’’
therapeutics for leukemia. Such therapies could be directed at
normalizing the turnover of aberrantly stabilized mRNAs by
targeting pathways or protein/RNA interactions responsible for
coordinated transcript stabilization in malignancy.
Materials and Methods
Cells and Culture
32Dcl3 cells (gift from Alan Friedman, Johns Hopkins
University) were cultured in RPMI 1640 media supplemented
with 10% fetal bovine serum as previously described [27] using
murine IL-3 (Peprotech, Rocky Hill, NJ) at 1.5 ng/ml during cell
passaging. To generate stable clones lacking UTR sequences,
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32Dcl3 cells were transduced with retroviral supernatants
prepared to express human p21 from an engineered pMig
construct (MIGhp21wt) as described below. Transduced cells
were sorted on the basis of GFP expression. 32Dcl3 cells
expressing the entire human p21 gene were transfected with pC-
WAF1-S (gift from Wafik El-Deiry, U of Pennsylvania) and
selected in hygromycin. To generate stable clones bearing eGFP
with or without IL6- UTR sequences, cells were electroporated
using Amaxa electroporation per manufacturer’s guidelines
(Amaxa, Inc., Gaithersburg, MD) for 32Dcl3 cells, using 1026
cells and 2.0 ug DNA, followed by neomycin selection. V-Abl cells
were generated as previously described [2].
Plasmids
Retroviral constructs were derived from the MIG plasmid (gift
from Luk Van Parijs, Massachusetts Institute of Technology)
which we modified into a GatewayH destination vector (Invitro-
gen, Carlsbad, CA). Human p21 wild-type cDNA (accession#
NM_078467) coding region carrying a myc-his tag was cloned into
this using GatewayH technology. To generate pEGFP-IL6-UTR,
the plasmid pEGFP-N1 (Clontech, Inc., Mountainview, CA) was
digested at the Not1 site, dephosphorylated, and ligated with a
PCR-generated fragment encompassing bp 740–898 of murine
IL6 (Accession NM_031168) generated with Eag1 and Not1
bounded primers that was digested with Eag1 prior to ligation.
Retroviral Transduction
Retroviruses were generated and transduced into 32Dcl3 cells
as previously described [51].
RNA Half-life determination
32Dcl3 cells were washed free of IL-3 and resuspended in IL-3-
free medium. Actinomycin-D (Sigma-Aldrich) was added at
10 mg/mL, a concentration that we have previously shown to
suppress transcription in 32Dcl3 cells [2]. Twenty minutes after
Actinomycin D addition, the culture was divided into aliquots for
growth factor addition. IL-3 was added at a final concentration of
either 1 ng/mL, 10 pg/mL or absent and RNA was prepared at
time points as noted. For half-life assessments made in G-CSF,
cells were washed free of IL-3 and incubated in G-CSF for
18 hours. Actinomycin D was added at time 215 minutes and cell
cultures were divided into two equal parts. Cells in G-CSF
received either 1 ng/mL IL-3 or no cytokine 15 minutes after
Actinomycin D addition. RNA was prepared at denoted time
points after cytokine addition. Northern blotting for all experi-
ments was performed as previously described [27]. Signal density
analysis of scanned images was performed using Image J 1.31v
software (http://rsb.info.nih.gov/ij). Multiple exposures were
obtained to optimize linearity of signal. Half-life determination
was calculated from logarithmic trendlines fitted to the plotted
data of signal magnitude (normalized to time 0) versus time.
Riboprobes
Templates for riboprobes were generated using RT-PCR of
mRNA purified from 32Dcl3 cells or by amplification from plasmid
templates using T7-linked antisense oligomers. A full listing of PCR
sequences used to amplify probes is available on request. 32[P]-UTP
labeled riboprobes were generated in vitro using a T7-Maxi-Script kit
(Ambion, Houston, TX) per manufacturer’s instructions.
Statistics
Protein and RNA half-life determinations were compared for all
conditions tested with significance assessed by a 2-tailed, type 2
student’s t-test using 95% confidence intervals. All calcula-
tions were made using the Excel software package (Microsoft,
Redmond, WA).
Gene Ontology Analysis
We analyzed the top 1000 probe sets for enrichment of the
corresponding genes belonging to common Gene Ontology (GO)
categories. The base set of genes was all genes on the microarray.
The GO analysis was done using the STEM software [31] the
p-values based on the hypergeometric distribution. GO enrich-
ment p-values were corrected for multiple hypothesis testing using
randomization analysis.
Microarray Normalization
Most microarray normalization methods assume that the total
mRNA quantity will remain constant across the different arrays
and time points. This assumption is not applicable to the kinetic
microarray experiments conducted to measure mRNA decay,
because later time points followed transcriptional blockade. We
thus evaluated several normalization programs (dChip, MAS 5,
and RMA) to determine which would be most consistent with our
expectation that the mRNA levels at time point 0 would contribute
a greater signal than time points after transcriptional inhibition.
Using thiscriteria we selected the dChip normalization (see
Supplemental Methods S1 for details). All ten microarray
hybridizations were normalized together using the dChip software
with the default settings.
Scoring Probe Sets
The probe sets were ranked for IL-3 induced stability based on
the signed area between a curve for the high IL-3 experiment and
the low IL-3 experiment. For each probe set, the signed area
values were averaged over the two replicates and divided by a
variability term. The variability term was a function of the average
intensity of the probe set for the 0 hour time point. This function
was computed based on the variability of the area between the
replicates for probe sets with similar average 0 hour probe set
intensity. See Supplemental Methods S1 for full details.
Data Accession
Microarray data is available at http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc =GSE12067.
all microarray data reported in the manuscript is described in
accordance with MIAME guidelines.
Supporting Information
Supplemental Methods S1 Detailed methods related to
microarray normalization and probeset ranking.
Found at: doi:10.1371/journal.pone.0007469.s001 (0.62 MB
DOC)
Supplemental Table S1 Affymetrix 430A probe sets ranked
from most stabilized by IL-3 to least stabilized according to
normalized area score. Gene symbols and identifiers are included.
Found at: doi:10.1371/journal.pone.0007469.s002 (3.02 MB
XLS)
Supplemental Table S2 Unique transcripts according to
Entrez ID ranked from most stabilized by IL-3 to least stabilized
according to normalized area score. Score shown is the average
score of all probe sets that were linked to the given transcript.
Gene symbols and Entrez ID identifiers are included.
Found at: doi:10.1371/journal.pone.0007469.s003 (1.12 MB
XLS)
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Supplemental Table S3 Gene Ontology Analysis conducted on
the 1000 transcripts most-stabilized by IL-3. Analysis conducted as
described in text.
Found at: doi:10.1371/journal.pone.0007469.s004 (0.05 MB
PDF)
Supplemental Table S4 Excess occurrence of ARE motifs
among transcripts most stabilized by IL-3. See text for details.
Sheet 1 lists all probe sets from most stabilized (position 2) to least
stabilized (position 22691). A value (‘‘1’’) is ascribed to each probe
set with a human match to the ARED database (Reference 26) and
a ‘‘0’’ value to those lacking a match. Cumulative ARED-
containing transcripts in the rank list compared to random
ordering (observed minus expected) is derived from this chart as
discussed in the text.
Found at: doi:10.1371/journal.pone.0007469.s005 (4.02 MB
XLS)
Figure S1 Schematic of data collection for global transcript
decay analysis. Following actinomycin D addition, cells were
cultured in IL-3 replete or deficient medium starting at time 0. In
followup Northern Blot experiments, pathway inhibitors were
added 15–20 minutes before IL-3 or vehicle control was added.
Found at: doi:10.1371/journal.pone.0007469.s006 (0.07 MB TIF)
Figure S2 Top: Stability plots of myeloblast transcript probe sets
determined using kinetic microarrays. In these plots, the garea
value (y-axis) is plotted against the intensity of the probe signal at
time 0 (x-axis. Increased stability correlates with positions farthest
from the origin. The highest ranked 250, 1000, or 2000 probe sets
based on gscore as well as all probe sets with positive garea values
(5290 total) are shown and highlighted by color. The plots of the
top 250 Blue), 1000 (red), and 2000 (green) and all positive probe
sets (grey) in terms of the difference between their decay curve in
IL-3 -replete and -deficient medium are overlaid. The top 15
ranking probe sets are labeled with their corresponding gene
names. The identities and ranking of all 22,690 probe sets can be
found in Supplemental Table 1. The top 1000 probesets account
for 53% of the total cumulative garea attributable to IL3-
stabilization. Bottom: The difference between transcript half-lifes
in IL3 and in IL3-deficient conditions (normalized area score) is
plotted for 22690 probe sets arranged from most stabilized by IL-3
(positive values) to least stabilized by IL-3 (negative values; less
stable in IL-3). The broken axis facilitates notation of the last
probeset (rank 22690) with a value of 2148. The region
corresponding to the indicated probesets on the top graph is
circled.
Found at: doi:10.1371/journal.pone.0007469.s007 (0.17 MB TIF)
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